Pentagon Medical Research Funding Doubles to $1.27 Billion for FY2026

The Department of Defense's Congressionally Directed Medical Research Programs (CDMRP) received $1.27 billion for fiscal year 2026 — nearly double the $650 million allocated in FY2025. President Trump signed the funding into law on February 3, 2026, as part of the Consolidated Appropriations Act, supporting 34 distinct research programs.

Where the Biggest Funding Increases Landed

Several programs saw dramatic expansions:

• Peer Reviewed Medical Research Program: $370 million, up from $150 million
• Peer Reviewed Cancer Research Program: $165 million, up from $130 million
• Ovarian Cancer Research: $50 million, more than tripling from $15 million
• Traumatic Brain Injury and Psychological Health: $45 million in new dedicated funding

These increases reflect bipartisan congressional priorities around military-connected health conditions and translational research that can move rapidly from bench to bedside.

What Makes CDMRP Different from NIH Grants

Unlike the National Institutes of Health, CDMRP does not operate on a payline system. There is no predetermined funding line, percentage cutoff, or numerical score threshold that applications must meet. Instead, the program emphasizes high-risk, high-reward research with rapid translational potential — making it particularly attractive for researchers whose proposals might be considered too unconventional for traditional federal funders.

The program is also broadly inclusive in its eligibility. Universities, independent research institutions, and for-profit companies can all apply, a wider aperture than many federal funding mechanisms offer.

With nearly twice the available funding this year, competition ratios should improve compared to FY2025. But the surge in available capital will likely attract a larger applicant pool, so early preparation remains essential.

How Researchers Can Position Themselves Now

CDMRP posts program solicitations on Grants.gov and through the electronic Biomedical Research Application Portal (eBRAP). The standard cycle involves a pre-application screening period of four to six weeks after announcement, followed by full proposal invitations two to four weeks later.

Researchers with proposals aligned to cancer, traumatic brain injury, and psychological health priorities should begin preparing pre-applications now. Grant seekers can compare CDMRP deadlines to other federal opportunities on grantedai.com.

For more in-depth analysis of defense research funding trends, visit the Granted blog.